Yet, in a recent lung adenocarcinoma model, K-rasG12D expression promoted recruitment of Th17 cells to the tumor and increased tumor growth, with IL-17 blockade reducing tumor burden [77]. This evidence concerns the gene IL17A and neoplasm.